论文部分内容阅读
目的探讨肺表面活性物质(PS)治疗新生儿肺透明膜病(HMD)的临床护理体会。方法 30例应用肺表面活性物质治疗新生儿肺透明膜病的患儿,给予肺表面活性物质治疗时采用专业护理措施,观察患儿血气指标、护理结局。结果护理后,患儿的血气指标均明显优于护理前,差异具有统计学意义(P<0.05)。应用肺表面活性物质的30例患儿经过专业护理人员护理,病情较轻的患儿(24例)在4 d内脱离危险期,病情严重的患儿(6例)在8 d内脱离危险期,护理过程中未发生感染情况及不良事件。结论科学、有效的护理措施能够辅助提高肺表面活性物质治疗新生儿肺透明膜病的治疗效果,在减少感染、不良事件及提高护理质量上作用突出,值得推广。
Objective To investigate the clinical experience of pulmonary surfactant (PS) in the treatment of neonatal hyaline membrane disease (HMD). Methods Thirty patients with pulmonary surfactant were used to treat neonates with hyaline membrane disease. Special nursing interventions were given to pulmonary surfactant to observe the blood gas index and the nursing outcome. Results After nursing, the blood gas indexes in children were significantly better than those before nursing, the difference was statistically significant (P <0.05). Thirty children with pulmonary surfactant were given care by professional nursing staff. Twenty-four infants with mild illness were out of danger within 4 days. Six children with serious illness were out of danger stage within 8 days No infection and adverse events occurred during the nursing. Conclusion Scientific and effective nursing interventions can help to improve the therapeutic effect of pulmonary surfactant in the treatment of neonatal hyaline membrane disease, and play an important role in reducing infection, adverse events and improving the quality of nursing. It is worth to be popularized.